John Wiley & Sons (WLYB) Financials

$43.21 -0.05 (-0.11%)

As of 01:30 PM Eastern

Annual Income Statements for John Wiley & Sons

This table shows John Wiley & Sons' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	4/30/2024	4/30/2023	4/30/2022	4/30/2021	4/30/2020	4/30/2019	4/30/2018	4/30/2017	4/30/2016	4/30/2015
Net Income / (Loss) Attributable to Common Shareholders	-200	17	148	148	-74	168	192	114	146	177
Consolidated Net Income / (Loss)	-200	17	148	148	-74	168	192	114	146	177
Net Income / (Loss) Continuing Operations	-200	17	148	148	-74	168	192	114	146	177
Total Pre-Tax Income	-187	33	210	176	-63	213	214	191	175	225
Total Operating Income	52	56	219	186	-54	224	231	211	188	238
Total Gross Profit	1,293	1,327	1,382	1,316	1,240	1,245	1,265	1,218	1,261	1,323
Total Revenue	1,873	2,020	2,083	1,942	1,831	1,800	1,796	1,719	1,727	1,822
Operating Revenue	1,873	2,020	2,083	1,942	1,831	1,800	1,796	1,719	1,727	1,822
Total Cost of Revenue	580	693	701	625	591	555	531	501	466	500
Operating Cost of Revenue	580	693	701	625	591	555	531	501	466	500
Total Operating Expenses	1,241	1,271	1,163	1,131	1,295	1,021	1,034	1,006	1,073	1,085
Selling, General & Admin Expense	1,014	1,037	1,080	1,023	997	964	953	943	994	1,005
Amortization Expense	56	85	85	75	62	55	48	50	50	51
Impairment Charge	108	100	0.00	0.00	202	0.00	3.60	-	-	-
Restructuring Charge	63	49	-1.43	33	33	3.12	29	13	29	29
Total Other Income / (Expense), net	-239	-23	-9.62	-9.60	-8.81	-11	-18	-20	-13	-12
Interest Expense	49	38	20	18	25	16	13	17	17	17
Other Income / (Expense), net	-190	15	10	8.78	16	5.08	-4.26	-3.42	0.47	1.74
Income Tax Expense	13	16	61	28	11	45	22	77	29	49
Basic Earnings per Share	($3.65)	$0.31	$2.66	$2.65	($1.32)	$2.94	$3.37	$1.98	$2.51	$3.01
Weighted Average Basic Shares Outstanding	54.95M	55.56M	55.76M	55.93M	56.21M	57.19M	57.04M	57.34M	58.00M	58.73M
Diluted Earnings per Share	($3.65)	$0.31	$2.62	$2.63	($1.32)	$2.91	$3.32	$1.95	$2.48	$2.97
Weighted Average Diluted Shares Outstanding	54.95M	56.36M	56.60M	56.46M	56.21M	57.84M	57.89M	58.20M	58.73M	59.59M
Weighted Average Basic & Diluted Shares Outstanding	54.43M	55.28M	55.75M	55.85M	55.86M	57.20M	57M	57.40M	58.10M	58.80M

This table shows John Wiley & Sons' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-23	40	-1.44	25	-114	-19	-92	68	-71	38	-18
Consolidated Net Income / (Loss)	-23	40	-1.44	25	-114	-19	-92	68	-71	38	-18
Net Income / (Loss) Continuing Operations	-23	40	-1.44	25	-114	-19	-92	68	-71	38	-18
Total Pre-Tax Income	19	49	23	54	-112	-22	-107	86	-77	48	-23
Total Operating Income	52	64	29	69	-46	46	-16	82	-67	57	-17
Total Gross Profit	300	320	295	345	317	337	294	352	317	345	314
Total Revenue	405	427	404	468	461	493	451	526	491	515	488
Operating Revenue	405	427	404	468	461	493	451	526	491	515	488
Total Cost of Revenue	104	107	109	123	144	156	157	174	174	170	174
Operating Cost of Revenue	104	107	109	123	144	156	157	174	174	170	174
Total Operating Expenses	249	255	266	276	363	291	310	269	384	287	331
Selling, General & Admin Expense	230	239	249	252	253	252	256	246	256	253	283
Amortization Expense	13	13	13	13	14	14	16	19	20	20	25
Impairment Charge	0.00	0.00	0.00	-	82	0.00	27	-	100	0.00	0.00
Restructuring Charge	5.57	3.63	3.87	11	15	25	12	4.19	8.81	14	22
Total Other Income / (Expense), net	-33	-15	-5.97	-15	-66	-68	-90	3.14	-10	-9.11	-6.42
Interest Expense	14	14	13	11	13	13	11	11	12	9.33	6.33
Other Income / (Expense), net	-19	-0.73	6.82	-3.37	-53	-55	-79	14	1.13	0.22	-0.09
Income Tax Expense	42	8.48	24	29	1.58	-2.59	-14	17	-5.98	10	-5.55
Basic Earnings per Share	($0.43)	$0.75	($0.03)	$0.45	($2.08)	($0.35)	($1.67)	$1.23	($1.29)	$0.69	($0.32)
Weighted Average Basic Shares Outstanding	53.95M	54.19M	54.38M	54.95M	54.81M	55.10M	55.27M	55.56M	55.51M	55.62M	55.74M
Diluted Earnings per Share	($0.43)	$0.74	($0.03)	$0.45	($2.08)	($0.35)	($1.67)	$1.24	($1.29)	$0.68	($0.32)
Weighted Average Diluted Shares Outstanding	53.95M	54.85M	54.38M	54.95M	54.81M	55.10M	55.27M	56.36M	55.51M	56.20M	55.74M
Weighted Average Basic & Diluted Shares Outstanding	53.85M	54.03M	54.28M	54.43M	54.73M	54.87M	55.21M	55.28M	55.45M	55.56M	55.70M

This table details how cash moves in and out of John Wiley & Sons' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	4/30/2024	4/30/2023	4/30/2022	4/30/2021	4/30/2020	4/30/2019	4/30/2018	4/30/2017	4/30/2016	4/30/2015
Net Change in Cash & Equivalents	-7.72	6.54	6.37	-109	109	-77	108	-305	-94	-29
Net Cash From Operating Activities	208	277	339	360	288	251	382	315	350	355
Net Cash From Continuing Operating Activities	208	277	339	360	288	251	382	315	350	355
Net Income / (Loss) Continuing Operations	-200	17	148	148	-74	168	192	114	146	177
Consolidated Net Income / (Loss)	-200	17	148	148	-74	168	192	114	146	177
Depreciation Expense	98	96	95	91	77	69	64	67	66	62
Amortization Expense	79	117	120	109	98	92	206	205	199	202
Non-Cash Adjustments To Reconcile Net Income	398	185	80	111	270	21	34	95	58	49
Changes in Operating Assets and Liabilities, net	-167	-139	-104	-100	-83	-99	-114	-165	-119	-134
Net Cash From Investing Activities	-107	-98	-194	-433	-347	-302	-177	-243	-151	-280
Net Cash From Continuing Investing Activities	-107	-98	-194	-433	-347	-302	-177	-243	-151	-280
Purchase of Property, Plant & Equipment	-76	-81	-89	-77	-89	-77	-114	-105	-86	-69
Acquisitions	-13	-9.87	-82	-330	-231	-200	-27	-155	-20	-172
Sale of Property, Plant & Equipment	0.00	16	3.38	0.00	0.00	-	-	-	-	-
Other Investing Activities, net	-17	-23	-27	-26	-27	-24	-37	-44	-45	-38
Net Cash From Financing Activities	-107	-169	-132	-47	173	-18	-97	-346	-286	-61
Net Cash From Continuing Financing Activities	-107	-169	-132	-47	173	-18	-97	-346	-286	-61
Repayment of Debt	-1,161	-1,054	-668	-544	-635	-482	-472	-923	-613	-718
Repurchase of Common Equity	-45	-35	-30	-16	-47	-60	-40	-50	-70	-62
Payment of Dividends	-77	-77	-77	-77	-77	-76	-74	-72	-70	-68
Issuance of Debt	1,185	1,005	651	593	934	596	459	683	467	759
Other Financing Activities, net	-8.50	-8.00	-7.11	-3.43	-3.79	3.75	29	16	0.93	29
Other Net Changes in Cash	-1.49	-3.57	-7.07	12	-4.94	-	-	-31	-	-
Cash Interest Paid	47	36	18	17	24	15	12	16	15	15
Cash Income Taxes Paid	51	51	49	41	42	48	49	34	39	46

This table details how cash moves in and out of John Wiley & Sons' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Change in Cash & Equivalents	29	-14	-10	-9.36	9.29	-7.64	-0.01	-20	7.93	14	4.26
Net Cash From Operating Activities	146	-5.28	-89	183	108	-1.15	-82	223	130	14	-90
Net Cash From Continuing Operating Activities	146	-5.28	-89	183	108	-1.15	-82	223	130	14	-90
Net Income / (Loss) Continuing Operations	-23	40	-1.44	25	-114	-19	-92	68	-71	38	-18
Consolidated Net Income / (Loss)	-23	40	-1.44	25	-114	-19	-92	68	-71	38	-18
Depreciation Expense	19	20	20	29	27	20	21	23	24	24	25
Amortization Expense	17	17	17	18	18	20	22	27	29	28	34
Non-Cash Adjustments To Reconcile Net Income	38	25	14	60	153	74	111	14	115	29	28
Changes in Operating Assets and Liabilities, net	95	-107	-139	50	24	-96	-145	91	34	-106	-158
Net Cash From Investing Activities	-25	-21	-24	-28	-27	-26	-26	-18	-32	-26	-22
Net Cash From Continuing Investing Activities	-25	-21	-24	-28	-27	-26	-26	-18	-32	-26	-22
Purchase of Property, Plant & Equipment	-13	-15	-15	-19	-17	-20	-20	-24	-19	-21	-18
Acquisitions	-3.12	-1.73	-7.30	-10	-2.85	-	-1.50	-4.08	-5.70	-	-0.10
Other Investing Activities, net	-8.77	-4.42	-2.00	-0.40	-5.74	-6.51	-4.61	-6.25	-7.00	-5.92	-3.79
Net Cash From Financing Activities	-89	11	102	-163	-74	24	106	-224	-96	34	118
Net Cash From Continuing Financing Activities	-89	11	102	-163	-74	24	106	-224	-96	34	118
Repayment of Debt	-301	-312	-313	-409	-368	-182	-202	-558	-270	-108	-116
Repurchase of Common Equity	-10	-13	-13	-16	-6.50	-13	-10	-11	-6.50	-7.50	-10
Payment of Dividends	-19	-19	-19	-19	-19	-19	-19	-19	-19	-19	-19
Issuance of Debt	241	356	450	285	320	238	342	367	201	169	269
Other Financing Activities, net	-0.16	-0.22	-3.75	-2.99	-0.91	-0.28	-4.33	-2.53	-0.71	-0.04	-4.72
Other Net Changes in Cash	-3.06	0.64	0.80	-1.93	2.38	-4.20	2.26	-0.90	6.11	-6.80	-1.99
Cash Interest Paid	14	14	12	11	13	12	11	10	12	8.57	5.51
Cash Income Taxes Paid	14	20	9.17	12	12	14	12	12	13	11	14

This table presents John Wiley & Sons' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	4/30/2024	4/30/2023	4/30/2022	4/30/2021	4/30/2020	4/30/2019	4/30/2018	4/30/2017	4/30/2016	4/30/2015
Total Assets	2,725	3,109	3,362	3,446	3,169	2,949	2,839	2,606	2,921	3,004
Total Current Assets	454	541	551	526	615	503	480	360	671	741
Cash & Equivalents	83	107	100	94	202	93	170	59	364	457
Accounts Receivable	224	310	332	312	309	307	212	189	168	147
Inventories, net	26	31	37	43	44	36	39	48	58	64
Prepaid Expenses	86	94	82	78	59	67	58	65	81	73
Other Current Nonoperating Assets	34	0.00	-	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	192	247	272	282	298	289	290	243	215	193
Total Noncurrent Assets	2,079	2,320	2,539	2,638	2,256	2,157	2,070	2,003	2,036	2,070
Goodwill	1,091	1,204	1,302	1,304	1,117	1,096	1,020	982	952	962
Intangible Assets	616	855	931	1,015	807	866	848	828	877	918
Other Noncurrent Operating Assets	353	262	306	318	332	196	202	193	144	133
Other Noncurrent Nonoperating Assets	19	0.00	-	-	-	-	-	-	-	-
Total Liabilities & Shareholders' Equity	2,725	3,109	3,362	3,446	3,169	2,949	2,839	2,606	2,921	3,004
Total Liabilities	1,986	2,064	2,219	2,355	2,235	1,767	1,649	1,603	1,884	1,949
Total Current Liabilities	873	896	969	989	927	882	874	788	782	804
Short-Term Debt	7.50	5.00	19	13	9.38	0.00	-	-	-	100
Accounts Payable	56	84	77	96	94	91	90	76	166	161
Accrued Expenses	97	113	102	79	87	78	73	63	-	-
Current Deferred Revenue	484	-	538	-	-	-	-	436	426	372
Current Employee Benefit Liabilities	97	80	117	145	108	97	116	104	103	99
Other Current Liabilities	95	612	116	657	615	595	581	86	76	62
Other Current Nonoperating Liabilities	38	0.00	-	-	-	-	-	-	-	-
Total Noncurrent Liabilities	1,112	1,312	1,250	1,366	1,308	885	775	815	1,102	1,146
Long-Term Debt	767	743	768	809	766	479	360	365	605	650
Noncurrent Deferred & Payable Income Tax Liabilities	97	288	180	173	119	144	144	160	190	199
Noncurrent Employee Benefit Liabilities	71	86	79	146	188	166	190	215	224	210
Other Noncurrent Operating Liabilities	166	195	223	238	235	96	81	75	83	87
Other Noncurrent Nonoperating Liabilities	11	0.00	-	-	-	-	-	-	-	-
Commitments & Contingencies	0.00	0.00	-	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	740	1,045	1,142	1,091	850	1,181	1,191	1,003	1,037	1,055
Total Preferred & Common Equity	740	1,045	1,142	1,091	934	1,181	1,191	1,003	1,037	1,055
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	740	1,045	1,139	1,091	850	1,181	1,191	1,003	1,037	1,055
Common Stock	558	553	542	528	432	505	490	471	452	436
Retained Earnings	1,583	1,861	1,921	1,850	1,780	1,931	1,834	1,715	1,673	1,597
Treasury Stock	-873	-840	-813	-796	-786	-746	-694	-676	-640	-572
Accumulated Other Comprehensive Income / (Loss)	-528	-529	-512	-491	-575	-509	-440	-507	-448	-407

This table presents John Wiley & Sons' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	1/31/2024	10/31/2023	7/31/2023	1/31/2023	10/31/2022	7/31/2022	1/31/2022
Total Assets	2,600	2,609	2,652	2,707	2,779	2,926	3,150	3,128	3,229	3,378
Total Current Assets	395	370	393	384	426	478	531	483	501	492
Cash & Equivalents	105	76	83	93	83	75	126	118	104	109
Accounts Receivable	185	183	192	161	147	153	284	260	281	268
Inventories, net	25	27	26	28	30	30	33	34	33	40
Prepaid Expenses	80	85	87	69	59	80	88	70	81	74
Other Current Nonoperating Assets	0.00	0.00	5.28	33	106	139	-	-	-	-
Plant, Property, & Equipment, net	165	172	185	208	223	224	248	250	258	272
Total Noncurrent Assets	2,041	2,066	2,074	2,115	2,131	2,225	2,371	2,395	2,470	2,614
Goodwill	1,079	1,102	1,100	1,097	1,082	1,102	1,203	1,268	1,289	1,326
Intangible Assets	572	598	609	629	631	657	868	861	896	971
Other Noncurrent Operating Assets	389	366	365	370	216	224	299	267	285	318
Other Noncurrent Nonoperating Assets	0.00	0.00	0.02	19	203	241	-	-	-	-
Total Liabilities & Shareholders' Equity	2,600	2,609	2,652	2,707	2,779	2,926	3,150	3,128	3,229	3,378
Total Liabilities	1,915	1,854	1,938	1,959	1,912	1,989	2,123	2,051	2,147	2,258
Total Current Liabilities	717	561	689	712	610	706	761	635	781	821
Short-Term Debt	10	10	8.75	6.25	5.00	5.00	5.00	44	22	16
Accounts Payable	53	40	39	45	49	44	32	46	57	77
Accrued Expenses	156	119	105	151	106	99	154	102	94	141
Current Deferred Revenue	313	241	367	301	236	370	369	-	-	-
Current Employee Benefit Liabilities	74	61	49	78	83	52	81	84	80	105
Other Current Liabilities	110	90	96	97	90	86	119	358	528	466
Other Current Nonoperating Liabilities	0.00	0.00	24	34	42	50	-	-	-	-
Total Noncurrent Liabilities	1,197	1,292	1,250	1,247	1,302	1,283	1,362	1,416	1,366	1,437
Long-Term Debt	877	951	910	901	938	891	941	979	917	902
Noncurrent Deferred & Payable Income Tax Liabilities	95	99	97	95	94	110	145	157	160	183
Noncurrent Employee Benefit Liabilities	70	71	68	72	76	81	78	76	78	116
Other Noncurrent Operating Liabilities	156	171	169	169	180	185	199	205	212	236
Other Noncurrent Nonoperating Liabilities	0.00	0.00	5.97	9.70	14	15	-	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-
Total Equity & Noncontrolling Interests	685	755	714	748	867	937	1,027	1,078	1,082	1,120
Total Preferred & Common Equity	685	755	714	748	867	937	1,027	1,078	1,082	1,120
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	685	755	714	748	867	937	1,027	1,078	1,082	1,120
Common Stock	566	562	556	557	554	548	553	548	542	540
Retained Earnings	1,542	1,584	1,563	1,577	1,710	1,749	1,812	1,903	1,884	1,897
Treasury Stock	-903	-894	-882	-860	-855	-843	-832	-827	-820	-811
Accumulated Other Comprehensive Income / (Loss)	-519	-496	-524	-527	-542	-517	-506	-546	-523	-507

This table displays calculated financial ratios and metrics derived from John Wiley & Sons' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	4/30/2024	4/30/2023	4/30/2022	4/30/2021	4/30/2020	4/30/2019	4/30/2018	4/30/2017	4/30/2016	4/30/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.27%	-3.03%	7.28%	6.01%	1.75%	0.22%	4.51%	-0.49%	-5.23%	2.66%
EBITDA Growth	-86.29%	-36.11%	12.71%	187.96%	-64.89%	-21.61%	3.87%	5.67%	-9.92%	8.25%
EBIT Growth	-294.85%	-69.13%	18.10%	609.52%	-116.65%	0.82%	9.20%	10.32%	-21.25%	14.34%
NOPAT Growth	25.72%	-81.24%	-0.79%	511.43%	-121.47%	-14.88%	65.36%	-19.85%	-15.88%	9.93%
Net Income Growth	-1,262.42%	-88.38%	0.04%	299.57%	-144.15%	-12.45%	69.11%	-22.05%	-17.58%	10.19%
EPS Growth	-1,277.42%	-88.17%	-0.38%	299.24%	-145.36%	-12.35%	70.26%	-21.37%	-16.50%	10.00%
Operating Cash Flow Growth	-25.06%	-18.29%	-5.79%	24.78%	14.99%	-34.39%	21.41%	-10.02%	-1.45%	1.98%
Free Cash Flow Firm Growth	-17.94%	117.10%	192.81%	-778.86%	343.28%	-106.93%	44.84%	-58.27%	-3.62%	132.69%
Invested Capital Growth	-14.41%	-15.66%	0.54%	20.77%	-3.90%	13.50%	5.43%	2.45%	-5.15%	-3.46%
Revenue Q/Q Growth	-2.99%	-0.96%	0.45%	3.28%	-0.90%	0.78%	1.41%	1.05%	-0.42%	-0.84%
EBITDA Q/Q Growth	-46.06%	14.86%	0.42%	389.00%	-63.93%	-23.10%	2.93%	4.88%	-1.68%	2.02%
EBIT Q/Q Growth	-28.67%	124.84%	0.93%	950.27%	-117.84%	4.27%	7.87%	11.26%	-6.15%	2.95%
NOPAT Q/Q Growth	-20.76%	30.52%	3.90%	712.59%	-124.01%	5.63%	-0.02%	14.77%	-7.49%	6.91%
Net Income Q/Q Growth	-27.40%	316.36%	1.24%	390.03%	-150.54%	5.77%	4.00%	12.31%	-8.01%	6.64%
EPS Q/Q Growth	-27.62%	282.35%	1.16%	392.22%	-151.36%	5.82%	4.08%	12.72%	-7.81%	6.83%
Operating Cash Flow Q/Q Growth	-16.18%	18.24%	-6.73%	1.57%	0.30%	2.88%	38.31%	-31.91%	10.19%	1.88%
Free Cash Flow Firm Q/Q Growth	-23.59%	203.27%	-6.12%	-92.31%	200.96%	84.29%	1.69%	-40.86%	-4.78%	103.31%
Invested Capital Q/Q Growth	-15.01%	-16.44%	-5.13%	-5.90%	-19.77%	-7.60%	-5.96%	-6.11%	-11.53%	-10.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.05%	65.71%	66.36%	67.79%	67.73%	69.18%	70.43%	70.86%	73.01%	72.58%
EBITDA Margin	2.08%	14.07%	21.35%	20.32%	7.48%	21.68%	27.72%	27.89%	26.26%	27.63%
Operating Margin	2.79%	2.77%	10.53%	9.56%	-2.96%	12.44%	12.89%	12.31%	10.89%	13.05%
EBIT Margin	-7.37%	3.51%	11.02%	10.01%	-2.08%	12.73%	12.65%	12.11%	10.92%	13.14%
Profit (Net Income) Margin	-10.70%	0.85%	7.12%	7.64%	-4.06%	9.35%	10.70%	6.61%	8.44%	9.71%
Tax Burden Percent	107.10%	52.06%	70.74%	84.28%	117.74%	79.01%	89.84%	59.46%	83.40%	78.45%
Interest Burden Percent	135.50%	46.72%	91.37%	90.54%	165.45%	92.96%	94.16%	91.86%	92.69%	94.15%
Effective Tax Rate	0.00%	47.94%	29.26%	15.72%	0.00%	20.99%	10.16%	40.54%	16.60%	21.55%
Return on Invested Capital (ROIC)	2.56%	1.73%	8.50%	9.40%	-2.47%	12.01%	15.46%	9.72%	11.95%	13.60%
ROIC Less NNEP Spread (ROIC-NNEP)	-41.39%	-0.28%	7.54%	8.23%	-9.44%	8.98%	9.12%	5.30%	7.79%	9.79%
Return on Net Nonoperating Assets (RNNOA)	-25.00%	-0.15%	4.78%	5.87%	-4.84%	2.18%	2.06%	1.42%	1.99%	2.22%
Return on Equity (ROE)	-22.45%	1.58%	13.28%	15.27%	-7.31%	14.19%	17.52%	11.14%	13.94%	15.81%
Cash Return on Invested Capital (CROIC)	18.08%	18.71%	7.97%	-9.42%	1.50%	-0.64%	10.17%	7.30%	17.23%	17.11%
Operating Return on Assets (OROA)	-4.73%	2.19%	6.74%	5.87%	-1.25%	7.92%	8.34%	7.53%	6.37%	7.88%
Return on Assets (ROA)	-6.87%	0.53%	4.36%	4.48%	-2.43%	5.81%	7.06%	4.11%	4.92%	5.82%
Return on Common Equity (ROCE)	-22.45%	1.57%	13.26%	15.27%	-7.31%	14.19%	17.52%	11.14%	13.94%	15.81%
Return on Equity Simple (ROE_SIMPLE)	-27.08%	1.65%	12.98%	13.59%	-7.96%	14.24%	16.14%	11.33%	14.06%	16.76%
Net Operating Profit after Tax (NOPAT)	37	29	155	156	-38	177	208	126	157	186
NOPAT Margin	1.95%	1.44%	7.45%	8.05%	-2.07%	9.83%	11.58%	7.32%	9.08%	10.23%
Net Nonoperating Expense Percent (NNEP)	43.95%	2.00%	0.96%	1.17%	6.97%	3.03%	6.34%	4.42%	4.16%	3.80%
Cost of Revenue to Revenue	30.95%	34.29%	33.64%	32.21%	32.27%	30.82%	29.57%	29.14%	26.99%	27.42%
SG&A Expenses to Revenue	54.11%	51.36%	51.83%	52.67%	54.46%	53.53%	53.07%	54.89%	57.58%	55.15%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	66.26%	62.95%	55.83%	58.24%	70.69%	56.74%	57.55%	58.55%	62.11%	59.54%
Earnings before Interest and Taxes (EBIT)	-138	71	229	194	-38	229	227	208	189	239
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	39	284	445	394	137	390	498	479	454	503
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.76	1.95	2.29	2.62	2.15	1.89	2.59	2.40	2.15	2.41
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.09	1.01	1.25	1.47	1.00	1.24	1.72	1.40	1.29	1.39
Price to Earnings (P/E)	0.00	118.30	17.61	19.28	0.00	13.24	16.07	21.21	15.30	14.35
Dividend Yield	3.76%	3.78%	2.94%	2.68%	4.17%	4.24%	2.38%	3.66%	3.11%	2.68%
Earnings Yield	0.00%	0.85%	5.68%	5.19%	0.00%	7.55%	6.22%	4.71%	6.54%	6.97%
Enterprise Value to Invested Capital (EV/IC)	2.07	1.74	1.80	1.97	1.60	1.67	2.37	2.07	1.93	2.10
Enterprise Value to Revenue (EV/Rev)	1.46	1.33	1.58	1.85	1.31	1.45	1.83	1.58	1.43	1.55
Enterprise Value to EBITDA (EV/EBITDA)	70.14	9.43	7.42	9.09	17.54	6.70	6.59	5.67	5.45	5.62
Enterprise Value to EBIT (EV/EBIT)	0.00	37.83	14.37	18.46	0.00	11.41	14.43	13.06	13.11	11.82
Enterprise Value to NOPAT (EV/NOPAT)	74.67	92.11	21.26	22.94	0.00	14.77	15.77	21.61	15.75	15.18
Enterprise Value to Operating Cash Flow (EV/OCF)	13.16	9.67	9.73	9.96	8.33	10.42	8.57	8.63	7.06	7.97
Enterprise Value to Free Cash Flow (EV/FCFF)	10.55	8.50	22.70	0.00	104.18	0.00	23.97	28.77	10.92	12.06
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.05	0.72	0.69	0.75	0.91	0.41	0.30	0.36	0.58	0.71
Long-Term Debt to Equity	1.04	0.71	0.67	0.74	0.90	0.41	0.30	0.36	0.58	0.62
Financial Leverage	0.60	0.54	0.63	0.71	0.51	0.24	0.23	0.27	0.26	0.23
Leverage Ratio	3.27	2.96	3.05	3.41	3.01	2.44	2.48	2.71	2.83	2.72
Compound Leverage Factor	4.43	1.38	2.79	3.08	4.98	2.27	2.34	2.49	2.63	2.56
Debt to Total Capital	51.15%	41.73%	40.79%	42.95%	47.68%	28.84%	23.22%	26.68%	36.84%	41.55%
Short-Term Debt to Total Capital	0.50%	0.28%	0.97%	0.65%	0.58%	0.00%	0.00%	0.00%	0.00%	5.54%
Long-Term Debt to Total Capital	50.66%	41.45%	39.82%	42.30%	47.10%	28.84%	23.22%	26.68%	36.84%	36.01%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	48.85%	58.27%	59.02%	57.05%	52.32%	71.16%	76.78%	73.32%	63.16%	58.45%
Debt to EBITDA	19.89	2.63	1.77	2.08	5.66	1.23	0.72	0.76	1.33	1.49
Net Debt to EBITDA	17.75	2.26	1.54	1.84	4.18	0.99	0.38	0.64	0.53	0.58
Long-Term Debt to EBITDA	19.70	2.62	1.73	2.05	5.59	1.23	0.72	0.76	1.33	1.29
Debt to NOPAT	21.17	25.72	5.07	5.25	-20.39	2.71	1.73	2.90	3.86	4.02
Net Debt to NOPAT	18.90	22.05	4.43	4.66	-15.07	2.18	0.91	2.44	1.54	1.57
Long-Term Debt to NOPAT	20.97	25.54	4.95	5.18	-20.15	2.71	1.73	2.90	3.86	3.49
Altman Z-Score	1.77	2.02	2.20	2.07	1.70	2.39	2.76	2.55	2.27	2.37
Noncontrolling Interest Sharing Ratio	0.00%	0.17%	0.16%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.52	0.60	0.57	0.53	0.66	0.57	0.55	0.46	0.86	0.92
Quick Ratio	0.35	0.47	0.45	0.41	0.55	0.45	0.44	0.31	0.68	0.75
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	259	315	145	-157	23	-9.48	137	94	226	235
Operating Cash Flow to CapEx	272.92%	422.56%	396.76%	464.97%	325.57%	325.05%	334.71%	299.74%	405.05%	513.77%
Free Cash Flow to Firm to Interest Expense	5.28	8.36	7.34	-8.52	0.92	-0.59	10.30	5.58	13.54	13.75
Operating Cash Flow to Interest Expense	4.24	7.34	17.12	19.58	11.56	15.56	28.80	18.59	20.95	20.80
Operating Cash Flow Less CapEx to Interest Expense	2.68	5.60	12.81	15.37	8.01	10.77	20.20	12.39	15.78	16.75
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.64	0.62	0.61	0.59	0.60	0.62	0.66	0.62	0.58	0.60
Accounts Receivable Turnover	7.01	6.29	6.47	6.25	5.95	6.94	8.96	9.65	10.97	12.28
Inventory Turnover	20.36	20.58	17.71	14.52	14.93	14.78	12.16	9.48	7.67	7.18
Fixed Asset Turnover	8.52	7.79	7.52	6.69	6.24	6.22	6.74	7.51	8.47	9.55
Accounts Payable Turnover	8.28	8.56	8.09	6.60	6.40	6.13	6.38	4.13	2.85	3.29
Days Sales Outstanding (DSO)	52.06	58.01	56.38	58.37	61.38	52.62	40.75	37.84	33.27	29.73
Days Inventory Outstanding (DIO)	17.93	17.74	20.61	25.14	24.45	24.70	30.02	38.49	47.59	50.87
Days Payable Outstanding (DPO)	44.07	42.63	45.12	55.30	57.02	59.57	57.20	88.39	128.28	111.03
Cash Conversion Cycle (CCC)	25.92	33.12	31.87	28.21	28.81	17.74	13.57	-12.06	-47.43	-30.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,320	1,543	1,829	1,819	1,506	1,567	1,381	1,310	1,278	1,348
Invested Capital Turnover	1.31	1.20	1.14	1.17	1.19	1.22	1.34	1.33	1.32	1.33
Increase / (Decrease) in Invested Capital	-222	-286	9.82	313	-61	186	71	31	-69	-48
Enterprise Value (EV)	2,732	2,680	3,298	3,586	2,403	2,614	3,278	2,717	2,472	2,831
Market Capitalization	2,040	2,039	2,611	2,858	1,830	2,228	3,088	2,411	2,230	2,538
Book Value per Share	$13.51	$18.85	$20.44	$19.53	$15.17	$20.66	$20.74	$17.49	$17.97	$17.97
Tangible Book Value per Share	($17.67)	($18.28)	($19.65)	($21.99)	($19.15)	($13.64)	($11.80)	($14.08)	($13.71)	($14.05)
Total Capital	1,514	1,793	1,929	1,913	1,625	1,660	1,551	1,368	1,642	1,805
Total Debt	775	748	787	822	775	479	360	365	605	750
Total Long-Term Debt	767	743	768	809	766	479	360	365	605	650
Net Debt	691	642	687	728	573	386	190	306	241	293
Capital Expenditures (CapEx)	76	66	85	77	89	77	114	105	86	69
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-495	-456	-500	-544	-505	-473	-564	-487	-475	-420
Debt-free Net Working Capital (DFNWC)	-412	-349	-400	-450	-303	-380	-394	-428	-111	37
Net Working Capital (NWC)	-419	-354	-419	-463	-312	-380	-394	-428	-111	-63
Net Nonoperating Expense (NNE)	237	12	6.80	8.09	36	8.72	16	12	11	9.63
Net Nonoperating Obligations (NNO)	581	498	687	728	656	386	190	306	241	293
Total Depreciation and Amortization (D&A)	177	213	215	200	175	161	271	271	265	264
Debt-free, Cash-free Net Working Capital to Revenue	-26.43%	-22.57%	-24.01%	-28.02%	-27.60%	-26.26%	-31.41%	-28.32%	-27.50%	-23.06%
Debt-free Net Working Capital to Revenue	-21.98%	-17.29%	-19.19%	-23.19%	-16.54%	-21.10%	-21.96%	-24.91%	-6.43%	2.04%
Net Working Capital to Revenue	-22.38%	-17.54%	-20.09%	-23.83%	-17.05%	-21.10%	-21.96%	-24.91%	-6.43%	-3.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.65)	$0.31	$2.66	$2.65	($1.32)	$2.94	$3.37	$1.98	$2.51	$3.01
Adjusted Weighted Average Basic Shares Outstanding	54.95M	55.56M	55.76M	55.93M	56.21M	57.19M	57.04M	57.34M	58.00M	58.73M
Adjusted Diluted Earnings per Share	($3.65)	$0.31	$2.62	$2.63	($1.32)	$2.91	$3.32	$1.95	$2.48	$2.97
Adjusted Weighted Average Diluted Shares Outstanding	54.95M	56.36M	56.60M	56.46M	56.21M	57.84M	57.89M	58.20M	58.73M	59.59M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($1.32)	$2.94	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	54.43M	55.28M	55.75M	55.85M	55.86M	56.63M	57.50M	57.20M	57.58M	58.86M
Normalized Net Operating Profit after Tax (NOPAT)	157	107	154	184	126	179	237	134	181	209
Normalized NOPAT Margin	8.36%	5.29%	7.40%	9.50%	6.91%	9.97%	13.19%	7.78%	10.47%	11.47%
Pre Tax Income Margin	-9.99%	1.64%	10.07%	9.06%	-3.44%	11.83%	11.91%	11.12%	10.12%	12.37%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.82	1.88	11.59	10.57	-1.53	14.21	17.12	12.28	11.29	14.02
NOPAT to Interest Expense	0.75	0.77	7.83	8.50	-1.52	10.98	15.66	7.42	9.39	10.92
EBIT Less CapEx to Interest Expense	-4.37	0.14	7.27	6.36	-5.08	9.42	8.51	6.08	6.12	9.98
NOPAT Less CapEx to Interest Expense	-0.81	-0.97	3.52	4.29	-5.07	6.19	7.06	1.22	4.22	6.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-38.42%	448.55%	52.06%	51.90%	-103.19%	45.02%	38.27%	62.96%	47.95%	38.73%
Augmented Payout Ratio	-60.91%	651.65%	72.28%	62.53%	-165.91%	80.67%	58.92%	107.24%	95.95%	73.77%

This table displays calculated financial ratios and metrics derived from John Wiley & Sons' official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-12.17%	-13.44%	-10.47%	-10.96%	-6.24%	-4.28%	-7.50%	-3.58%	-4.75%	-3.41%	-0.17%
EBITDA Growth	229.29%	222.12%	241.39%	-22.73%	-296.66%	-71.77%	-225.32%	33.57%	-113.26%	-15.47%	-60.06%
EBIT Growth	133.04%	797.24%	137.52%	-31.98%	-50.12%	-115.77%	-459.30%	69.21%	-236.44%	-23.80%	-135.06%
NOPAT Growth	-96.12%	63.79%	84.20%	-51.12%	30.79%	-28.68%	3.60%	35.35%	-224.73%	-22.49%	-192.23%
Net Income Growth	79.84%	308.06%	98.44%	-63.03%	-59.33%	-150.91%	-417.32%	58.40%	-302.08%	-31.76%	-228.96%
EPS Growth	79.33%	311.43%	98.20%	-63.71%	-61.24%	-151.47%	-421.88%	63.16%	-304.76%	-31.31%	-233.33%
Operating Cash Flow Growth	35.61%	-358.73%	-7.75%	-17.94%	-16.99%	-108.38%	8.45%	23.66%	-44.51%	50.16%	-6.09%
Free Cash Flow Firm Growth	-91.62%	-121.17%	-128.88%	-27.75%	647.87%	374.67%	1,411.37%	806.95%	-19.33%	151.77%	113.46%
Invested Capital Growth	-5.50%	11.38%	9.14%	-14.41%	-15.85%	-25.68%	-24.74%	-15.66%	-4.24%	-3.35%	-2.17%
Revenue Q/Q Growth	-5.15%	5.64%	-13.80%	1.68%	-6.51%	9.27%	-14.28%	7.07%	-4.56%	5.59%	-10.64%
EBITDA Q/Q Growth	-30.91%	37.07%	-35.38%	311.26%	-272.13%	160.16%	-135.32%	1,184.51%	-112.25%	167.04%	-62.36%
EBIT Q/Q Growth	-48.42%	77.14%	-45.29%	166.09%	-988.47%	90.47%	-199.19%	245.86%	-214.34%	438.09%	-130.01%
NOPAT Q/Q Growth	-220.17%	3,031.47%	-105.62%	199.05%	-200.36%	382.76%	-117.39%	240.27%	-203.41%	482.23%	-124.41%
Net Income Q/Q Growth	-156.74%	2,917.41%	-105.68%	122.19%	-485.63%	78.92%	-235.00%	195.63%	-287.13%	314.15%	-141.34%
EPS Q/Q Growth	-158.11%	2,566.67%	-106.67%	121.63%	-494.29%	79.04%	-234.68%	196.12%	-289.71%	312.50%	-142.11%
Operating Cash Flow Q/Q Growth	2,869.73%	94.05%	-148.40%	69.96%	9,469.07%	98.60%	-136.86%	71.92%	845.31%	115.28%	-149.80%
Free Cash Flow Firm Q/Q Growth	119.01%	14.26%	-152.53%	-2.17%	-51.96%	16.96%	31.43%	912.65%	-69.51%	272.41%	-21.13%
Invested Capital Q/Q Growth	-10.53%	4.21%	19.25%	-15.01%	5.45%	2.11%	-6.48%	-16.44%	-6.87%	3.40%	4.81%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	74.24%	74.92%	72.95%	73.67%	68.82%	68.42%	65.17%	66.90%	64.58%	66.92%	64.31%
EBITDA Margin	17.10%	23.47%	18.09%	24.13%	-11.61%	6.31%	-11.45%	27.80%	-2.75%	21.38%	8.46%
Operating Margin	12.81%	15.03%	7.17%	14.68%	-10.07%	9.38%	-3.63%	15.68%	-13.65%	11.16%	-3.48%
EBIT Margin	8.08%	14.86%	8.86%	13.96%	-21.48%	-1.85%	-21.15%	18.28%	-13.42%	11.20%	-3.50%
Profit (Net Income) Margin	-5.67%	9.48%	-0.36%	5.39%	-24.72%	-3.95%	-20.46%	12.99%	-14.54%	7.42%	-3.66%
Tax Burden Percent	-122.93%	82.67%	-6.24%	46.79%	101.41%	88.27%	86.45%	79.83%	92.28%	79.03%	76.26%
Interest Burden Percent	57.10%	77.19%	64.27%	82.56%	113.46%	242.27%	111.88%	89.02%	117.47%	83.82%	137.13%
Effective Tax Rate	222.93%	17.33%	106.24%	53.21%	0.00%	0.00%	0.00%	20.17%	0.00%	20.97%	0.00%
Return on Invested Capital (ROIC)	-17.76%	14.05%	-0.54%	8.99%	-8.01%	7.46%	-3.00%	14.99%	-10.33%	9.02%	-2.62%
ROIC Less NNEP Spread (ROIC-NNEP)	-12.62%	12.36%	-0.49%	7.71%	-18.03%	0.59%	-15.06%	15.42%	-13.34%	8.25%	-3.31%
Return on Net Nonoperating Assets (RNNOA)	-13.98%	11.36%	-0.40%	4.65%	-16.50%	0.46%	-9.99%	8.35%	-10.11%	6.98%	-2.63%
Return on Equity (ROE)	-31.74%	25.41%	-0.95%	13.64%	-24.51%	7.92%	-12.99%	23.34%	-20.44%	16.00%	-5.25%
Cash Return on Invested Capital (CROIC)	9.70%	-37.72%	-4.21%	18.08%	19.93%	31.30%	30.59%	18.71%	5.51%	9.33%	9.02%
Operating Return on Assets (OROA)	5.19%	9.71%	5.80%	8.97%	-14.16%	-1.23%	-13.63%	11.41%	-8.38%	7.14%	-2.21%
Return on Assets (ROA)	-3.64%	6.19%	-0.23%	3.46%	-16.29%	-2.62%	-13.18%	8.11%	-9.09%	4.73%	-2.31%
Return on Common Equity (ROCE)	-31.74%	25.41%	-0.95%	13.64%	-24.51%	7.92%	-12.99%	23.30%	-20.44%	16.00%	-5.25%
Return on Equity Simple (ROE_SIMPLE)	6.03%	-6.57%	-15.34%	0.00%	-21.01%	-13.24%	-6.10%	0.00%	-0.78%	9.17%	10.78%
Net Operating Profit after Tax (NOPAT)	-64	53	-1.81	32	-32	32	-11	66	-47	45	-12
NOPAT Margin	-15.75%	12.43%	-0.45%	6.87%	-7.05%	6.57%	-2.54%	12.51%	-9.55%	8.82%	-2.44%
Net Nonoperating Expense Percent (NNEP)	-5.13%	1.68%	-0.05%	1.28%	10.02%	6.86%	12.06%	-0.42%	3.01%	0.78%	0.69%
Return On Investment Capital (ROIC_SIMPLE)	-4.05%	-	-	-	-1.96%	-	-	-	-	-	-
Cost of Revenue to Revenue	25.76%	25.08%	27.05%	26.33%	31.18%	31.58%	34.83%	33.10%	35.42%	33.08%	35.69%
SG&A Expenses to Revenue	56.83%	56.00%	61.62%	53.81%	55.00%	51.19%	56.72%	46.72%	52.06%	49.15%	57.99%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	61.43%	59.88%	65.78%	58.99%	78.89%	59.04%	68.79%	51.22%	78.23%	55.76%	67.79%
Earnings before Interest and Taxes (EBIT)	33	63	36	65	-99	-9.09	-95	96	-66	58	-17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	69	100	73	113	-54	31	-52	146	-13	110	41
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.23	3.54	3.64	2.76	2.40	1.86	1.94	1.95	2.34	2.04	2.50
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.30	1.52	1.42	1.09	0.93	0.82	0.92	1.01	1.18	1.07	1.30
Price to Earnings (P/E)	53.50	0.00	0.00	0.00	0.00	0.00	0.00	118.30	0.00	22.25	23.16
Dividend Yield	3.44%	2.85%	2.94%	3.76%	4.26%	4.77%	4.22%	3.78%	3.21%	3.51%	2.85%
Earnings Yield	1.87%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.85%	0.00%	4.49%	4.32%
Enterprise Value to Invested Capital (EV/IC)	2.04	2.17	2.18	2.07	1.68	1.68	1.83	1.74	1.75	1.57	1.84
Enterprise Value to Revenue (EV/Rev)	1.76	2.02	1.88	1.46	1.35	1.26	1.33	1.33	1.58	1.50	1.70
Enterprise Value to EBITDA (EV/EBITDA)	8.43	15.31	20.99	70.14	36.18	22.05	13.82	9.43	13.03	8.56	9.24
Enterprise Value to EBIT (EV/EBIT)	15.18	54.27	0.00	0.00	0.00	0.00	0.00	37.83	102.27	21.30	21.59
Enterprise Value to NOPAT (EV/NOPAT)	49.02	0.00	50.28	74.67	56.58	78.00	66.83	92.11	144.54	26.00	26.73
Enterprise Value to Operating Cash Flow (EV/OCF)	12.71	18.07	17.07	13.16	10.54	9.17	9.28	9.67	13.75	9.17	10.59
Enterprise Value to Free Cash Flow (EV/FCFF)	20.43	0.00	0.00	10.55	7.71	4.57	5.14	8.50	30.98	16.51	20.23
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.29	1.27	1.29	1.05	1.21	1.09	0.96	0.72	0.92	0.95	0.87
Long-Term Debt to Equity	1.28	1.26	1.27	1.04	1.20	1.08	0.95	0.71	0.92	0.91	0.85
Financial Leverage	1.11	0.92	0.83	0.60	0.92	0.78	0.66	0.54	0.76	0.85	0.79
Leverage Ratio	3.70	3.32	3.38	3.27	3.30	3.04	3.05	2.96	3.04	2.96	3.05
Compound Leverage Factor	2.11	2.56	2.17	2.70	3.74	7.36	3.41	2.63	3.57	2.48	4.18
Debt to Total Capital	56.42%	55.99%	56.28%	51.15%	54.79%	52.08%	48.87%	41.73%	47.94%	48.69%	46.46%
Short-Term Debt to Total Capital	0.64%	0.58%	0.54%	0.50%	0.38%	0.28%	0.27%	0.28%	0.25%	2.10%	1.08%
Long-Term Debt to Total Capital	55.79%	55.41%	55.74%	50.66%	54.41%	51.81%	48.60%	41.45%	47.69%	46.59%	45.38%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	43.58%	44.01%	43.72%	48.85%	45.21%	47.92%	51.13%	58.27%	52.06%	51.31%	53.54%
Debt to EBITDA	2.50	4.13	5.61	19.89	12.56	8.40	4.69	2.63	3.82	2.82	2.45
Net Debt to EBITDA	2.20	3.81	5.11	17.75	11.27	7.66	4.29	2.26	3.31	2.49	2.18
Long-Term Debt to EBITDA	2.47	4.09	5.56	19.70	12.47	8.36	4.66	2.62	3.80	2.70	2.40
Debt to NOPAT	14.52	-2.29	13.45	21.17	19.64	29.72	22.65	25.72	42.41	8.57	7.10
Net Debt to NOPAT	12.81	-2.11	12.24	18.90	17.63	27.10	20.75	22.05	36.74	7.57	6.31
Long-Term Debt to NOPAT	14.36	-2.27	13.32	20.97	19.51	29.56	22.53	25.54	42.19	8.20	6.93
Altman Z-Score	2.07	2.38	2.23	2.01	1.81	1.98	1.86	2.05	1.98	2.16	2.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.17%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.55	0.66	0.57	0.52	0.54	0.70	0.68	0.60	0.70	0.76	0.64
Quick Ratio	0.40	0.46	0.40	0.35	0.36	0.38	0.32	0.47	0.54	0.60	0.49
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	22	-115	-134	254	260	541	463	352	35	114	31
Operating Cash Flow to CapEx	1,098.16%	-36.34%	-611.72%	974.67%	636.06%	-5.69%	-409.91%	948.86%	680.68%	66.69%	-501.81%
Free Cash Flow to Firm to Interest Expense	1.55	-7.92	-10.45	22.30	19.53	41.85	40.84	33.35	3.02	12.22	4.84
Operating Cash Flow to Interest Expense	10.43	-0.37	-6.94	16.06	8.10	-0.09	-7.26	21.15	11.28	1.47	-14.20
Operating Cash Flow Less CapEx to Interest Expense	9.48	-1.37	-8.07	14.41	6.82	-1.65	-9.04	18.92	9.62	-0.74	-17.03
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.64	0.65	0.65	0.64	0.66	0.66	0.64	0.62	0.62	0.64	0.63
Accounts Receivable Turnover	9.86	10.66	10.57	7.01	8.68	9.63	9.12	6.29	7.39	7.48	7.36
Inventory Turnover	16.53	16.89	18.95	20.36	20.49	20.47	21.21	20.58	19.35	18.99	19.20
Fixed Asset Turnover	9.14	8.91	8.94	8.52	8.46	8.30	8.23	7.79	7.84	7.91	7.83
Accounts Payable Turnover	9.04	10.87	12.92	8.28	16.30	13.95	13.46	8.56	12.93	14.44	11.92
Days Sales Outstanding (DSO)	37.03	34.25	34.54	52.06	42.03	37.90	40.01	58.01	49.36	48.80	49.61
Days Inventory Outstanding (DIO)	22.08	21.62	19.26	17.93	17.81	17.83	17.21	17.74	18.86	19.22	19.01
Days Payable Outstanding (DPO)	40.39	33.56	28.26	44.07	22.40	26.17	27.12	42.63	28.23	25.27	30.62
Cash Conversion Cycle (CCC)	18.72	22.31	25.54	25.92	37.45	29.56	30.10	33.12	39.99	42.75	38.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,468	1,641	1,574	1,320	1,553	1,473	1,443	1,543	1,846	1,982	1,917
Invested Capital Turnover	1.13	1.13	1.21	1.31	1.14	1.14	1.18	1.20	1.08	1.02	1.07
Increase / (Decrease) in Invested Capital	-86	168	132	-222	-293	-509	-474	-286	-82	-69	-43
Enterprise Value (EV)	2,994	3,561	3,435	2,732	2,612	2,474	2,643	2,680	3,222	3,104	3,536
Market Capitalization	2,211	2,676	2,599	2,040	1,798	1,614	1,822	2,039	2,403	2,200	2,701
Book Value per Share	$12.68	$13.91	$13.11	$13.51	$13.64	$15.71	$16.95	$18.85	$18.48	$19.35	$19.41
Tangible Book Value per Share	($17.88)	($17.42)	($18.29)	($17.67)	($17.81)	($15.30)	($14.88)	($18.28)	($18.80)	($18.87)	($19.78)
Total Capital	1,572	1,716	1,632	1,514	1,655	1,810	1,833	1,793	1,972	2,101	2,021
Total Debt	887	961	919	775	907	943	896	748	946	1,023	939
Total Long-Term Debt	877	951	910	767	901	938	891	743	941	979	917
Net Debt	783	885	836	691	814	859	821	642	819	904	835
Capital Expenditures (CapEx)	13	15	15	19	17	20	20	24	19	21	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-417	-257	-370	-495	-415	-263	-298	-456	-351	-226	-363
Debt-free Net Working Capital (DFNWC)	-312	-181	-287	-412	-322	-180	-223	-349	-225	-108	-258
Net Working Capital (NWC)	-322	-191	-296	-419	-328	-185	-228	-354	-230	-152	-280
Net Nonoperating Expense (NNE)	-41	13	-0.37	6.91	81	52	81	-2.50	25	7.20	5.96
Net Nonoperating Obligations (NNO)	783	885	861	581	805	606	505	498	819	904	835
Total Depreciation and Amortization (D&A)	36	37	37	48	45	40	44	50	52	52	58
Debt-free, Cash-free Net Working Capital to Revenue	-24.48%	-14.59%	-20.25%	-26.43%	-21.49%	-13.40%	-15.04%	-22.57%	-17.22%	-10.95%	-17.41%
Debt-free Net Working Capital to Revenue	-18.34%	-10.30%	-15.73%	-21.98%	-16.67%	-9.16%	-11.25%	-17.29%	-11.02%	-5.21%	-12.40%
Net Working Capital to Revenue	-18.93%	-10.86%	-16.21%	-22.38%	-17.00%	-9.42%	-11.50%	-17.54%	-11.27%	-7.34%	-13.45%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.43)	$0.75	($0.03)	$0.45	($2.08)	($0.35)	($1.67)	$1.23	($1.29)	$0.69	($0.32)
Adjusted Weighted Average Basic Shares Outstanding	53.95M	54.19M	54.38M	54.95M	54.81M	55.10M	55.27M	55.56M	55.51M	55.62M	55.74M
Adjusted Diluted Earnings per Share	($0.43)	$0.74	($0.03)	$0.45	($2.08)	($0.35)	($1.67)	$1.24	($1.29)	$0.68	($0.32)
Adjusted Weighted Average Diluted Shares Outstanding	53.95M	54.85M	54.38M	54.95M	54.81M	55.10M	55.27M	56.36M	55.51M	56.20M	55.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.85M	54.03M	54.28M	54.43M	54.73M	54.87M	55.21M	55.28M	55.45M	55.56M	55.70M
Normalized Net Operating Profit after Tax (NOPAT)	40	56	23	56	35	50	16	69	29	56	3.83
Normalized NOPAT Margin	9.93%	13.13%	5.69%	11.92%	7.62%	10.13%	3.49%	13.15%	5.92%	10.96%	0.79%
Pre Tax Income Margin	4.61%	11.47%	5.70%	11.53%	-24.37%	-4.47%	-23.66%	16.27%	-15.76%	9.39%	-4.80%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.33	4.38	2.80	5.73	-7.43	-0.70	-8.42	9.11	-5.72	6.18	-2.69
NOPAT to Interest Expense	-4.54	3.67	-0.14	2.82	-2.44	2.50	-1.01	6.23	-4.07	4.86	-1.88
EBIT Less CapEx to Interest Expense	1.38	3.38	1.66	4.08	-8.70	-2.27	-10.19	6.88	-7.38	3.97	-5.52
NOPAT Less CapEx to Interest Expense	-5.49	2.66	-1.28	1.17	-3.71	0.94	-2.78	4.01	-5.73	2.66	-4.71
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	184.69%	-154.35%	-70.11%	-38.42%	-49.03%	-67.26%	-135.00%	448.55%	-971.40%	78.22%	66.33%
Augmented Payout Ratio	309.22%	-251.08%	-113.54%	-60.91%	-74.47%	-102.10%	-196.19%	651.65%	-1,337.16%	108.70%	94.30%

Frequently Asked Questions About John Wiley & Sons' Financials

When does John Wiley & Sons's fiscal year end?

According to the most recent income statement we have on file, John Wiley & Sons' financial year ends in April. Their financial year 2024 ended on April 30, 2024.

How has John Wiley & Sons' net income changed over the last 9 years?

John Wiley & Sons' net income appears to be on a downward trend, with a most recent value of -$200.32 million in 2024, falling from $176.87 million in 2015. The previous period was $17.23 million in 2023.

What is John Wiley & Sons's operating income?

John Wiley & Sons's total operating income in 2024 was $52.26 million, based on the following breakdown:

Total Gross Profit: $1.29 billion
Total Operating Expenses: $1.24 billion

How has John Wiley & Sons revenue changed over the last 9 years?

Over the last 9 years, John Wiley & Sons' total revenue changed from $1.82 billion in 2015 to $1.87 billion in 2024, a change of 2.8%.

How much debt does John Wiley & Sons have?

John Wiley & Sons' total liabilities were at $1.99 billion at the end of 2024, a 3.8% decrease from 2023, and a 1.9% increase since 2015.

How much cash does John Wiley & Sons have?

In the past 9 years, John Wiley & Sons' cash and equivalents has ranged from $58.52 million in 2017 to $457.44 million in 2015, and is currently $83.25 million as of their latest financial filing in 2024.

How has John Wiley & Sons' book value per share changed over the last 9 years?

Over the last 9 years, John Wiley & Sons' book value per share changed from 17.97 in 2015 to 13.51 in 2024, a change of -24.8%.

Related Companies

This page (NYSE:WLYB) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

John Wiley & Sons (WLYB) Financials

Frequently Asked Questions About John Wiley & Sons' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

John Wiley & Sons (WLYB) Financials

Annual Income Statements for John Wiley & Sons

Quarterly Income Statements for John Wiley & Sons

Annual Cash Flow Statements for John Wiley & Sons

Quarterly Cash Flow Statements for John Wiley & Sons

Annual Balance Sheets for John Wiley & Sons

Quarterly Balance Sheets for John Wiley & Sons

Annual Metrics And Ratios for John Wiley & Sons

Quarterly Metrics And Ratios for John Wiley & Sons

Frequently Asked Questions About John Wiley & Sons' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools